Citations for
1HNRNPH1, HNRNPH2, TYMP
Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance.
Stark M, Bram EE, Akerman M, Mandel-Gutfreund Y, Assaraf YG.
J Biol Chem 286(5):3741-54. doi: 10.1074/jbc.M110.163444. Epub 2010 Nov 10. 2011
2COX10, PINK1, TYMP
Therapeutic prospects for mitochondrial disease.
Schon EA, DiMauro S, Hirano M, Gilkerson RW.
Trends Mol Med. 16(6):268-76. 2010
3TYMP
Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach.
Halter J, Schüpbach WM, Casali C, Elhasid R, Fay K, Hammans S, Illa I, Kappeler L, Krähenbühl S, Lehmann T, Mandel H, Marti R, Mattle H, Orchard K, Savage D, Sue CM, Valcarcel D, Gratwohl A, Hirano M.
Bone Marrow Transplant. 2010
4TYMP
Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice.
López LC, Akman HO, García-Cazorla A, Dorado B, Martí R, Nishino I, Tadesse S, Pizzorno G, Shungu D, Bonilla E, Tanji K, Hirano M.
Hum Mol Genet. 18(4):714-22. 2009
5BNIP3, TYMP
Thymidine phosphorylase inhibits the expression of proapoptotic protein BNIP3.
Ikeda R, Tajitsu Y, Iwashita K, Che XF, Yoshida K, Ushiyama M, Furukawa T, Komatsu M, Yamaguchi T, Shibayama Y, Yamamoto M, Zhao HY, Arima J, Takeda Y, Akiyama S, Yamada K.
Biochem Biophys Res Commun 370(2):220-4. Epub 2008 Mar 24. 2008
6TYMP
Molecular basis for the involvement of thymidine phosphorylase in cancer invasion.
Gotanda T, Haraguchi M, Tachiwada T, Shinkura R, Koriyama C, Akiba S, Kawahara M, Nishiyama K, Sumizawa T, Furukawa T, Mimata H, Nomura Y, Akiyama S, Nakagawa M.
Int J Mol Med 17(6):1085-91. 2006
7TYMP
Pre- and post-dialysis quantitative dosage of thymidine in urine and plasma of a MNGIE patient by using HPLC-ESI-MS/MS.
la Marca G, Malvagia S, Casetta B, Pasquini E, Pela I, Hirano M, Donati MA, Zammarchi E.
J Mass Spectrom. 41(5):586-92. 2006
8TYMP
Infusion of platelets transiently reduces nucleoside overload in MNGIE.
Lara MC, Weiss B, Illa I, Madoz P, Massuet L, Andreu AL, Valentino ML, Anikster Y, Hirano M, Martí R.
Neurology. 67(8):1461-3. 2006
9TYMP, MNGIE
A novel thymidine phosphorylase mutation in a Spanish MNGIE patient.
Gamez J, Lara MC, Mearin F, Oliveras-Ley C, Raguer N, Olive M, Leist AT, Perello A, Perona M, Cervera C, Andreu AL, Marti R, Hirano M.
J Neurol Sci 228(1):35-9. Epub 2004 Nov 12. 2005
10TYMP, MNGIE
Thymidine phosphorylase gene mutations in patients with mitochondrial neurogastrointestinal encephalomyopathy syndrome.
Slama A, Lacroix C, Plante-Bordeneuve V, Lombes A, Conti M, Reimund JM, Auxenfants E, Crenn P, Laforet P, Joannard A, Seguy D, Pillant H, Joly P, Haut S, Messing B, Said G, Legrand A, Guiochon-Mantel A.
Mol Genet Metab 84(4):326-31. Epub 2005 Jan 24. 2005
11TYMP
Clinicopathological aspects of the neuropathy of neurogastrointestinal encephalomyopathy (MNGIE) in four patients including two with a Charcot-Marie-Tooth presentation.
Said G, Lacroix C, Plante-Bordeneuve V, Messing B, Slama A, Crenn P, Nivelon-Chevallier A, Bedenne L, Soichot P, Manceau E, Rigaud D, Guiochon-Mantel A, Matuchansky C.
J Neurol 252(6):655-62. Epub 2005 Mar 7. 2005
12MNGIE, TYMP
MNGIE with lack of skeletal muscle involvement and a novel TP splice site mutation.
Szigeti K, Wong LJ, Perng CL, Saifi GM, Eldin K, Adesina AM, Cass DL, Hirano M, Lupski JR, Scaglia F.
J Med Genet 41(2):125-9. 2004
13TYMP, MNGIE
Four novel thymidine phosphorylase gene mutations in mitochondrial neurogastrointestinal encephalomyopathy syndrome (MNGIE) patients.
Kocaefe YC, Erdem S, Ozguc M, Tan E.
Eur J Hum Genet 11(1):102-4. 2003
14TYMP
Significance of monocyte chemotactic protein-1 and thymidine phosphorylase in angiogenesis of human cardiac myxoma.
Zhang T, Koide N, Wada Y, Tsukioka K, Takayama K, Kono T, Kitahara H, Amano J.
Circ J 67(1):54-60. 2003
15TYMP
Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in mice.
Haraguchi M, Tsujimoto H, Fukushima M, Higuchi I, Kuribayashi H, Utsumi H, Nakayama A, Hashizume Y, Hirato J, Yoshida H, Hara H, Hamano S, Kawaguchi H, Furukawa T, Miyazono K, Ishikawa F, Toyoshima H, Kaname T, Komatsu M, Chen ZS, Gotanda T, Tachiwada T, Sumizawa T, Miyadera K, Osame M, Yoshida H, Noda T, Yamada Y, Akiyama S.
Mol Cell Biol. 22(14):5212-21. 2002
16TYMP
Altered thymidine metabolism due to defects of thymidine phosphorylase.
Spinazzola A, Marti R, Nishino I, Andreu AL, Naini A, Tadesse S, Pela I, Zammarchi E, Donati MA, Oliver JA, Hirano M.
J Biol Chem. 277(6):4128-33. 2002
17TYMP
Role of thymidine phosphorylase in Fas-induced apoptosis.
Mori S, Takao S, Ikeda R, Noma H, Mataki Y, Wang X, Akiyama S, Aiko T.
Hum Cell 14(4):323-30. 2001
18MNGIE, TYMP
Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder.
Nishino I, Spinazzola A, Hirano M.
Science 283(5402):689-92. 1999
19TYMP
Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis.
Brown NS, Bicknell R.
Biochem J 334 ( Pt 1):1-8. Review. 1998
20TYMP
Regional localization of the human platelet-derived endothelial cell growth factor (ECGF1) gene to chromosome 22q13.
Stenman G, Sahlin P, Dumanski JP, Hagiwara K, Ishikawa F, Miyazono K, Collins VP, Heldin CH.
Cytogenet Cell Genet 59 : 22-23. 1992
21TYMP
Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity.
Usuki K, Saras J, Waltenberger J, Miyazono K, Pierce G, Thomason A, Heldin CH.
Biochem Biophys Res Commun. 184(3):1311-6. 1992
22TYMP
Organization and chromosomal localization of the human platelet-derived endothelial cell growth factor gene.
Hagiwara K, Stenman G, Honda H, Sahlin P, Andersson A, Miyazono K, Heldin CH, Ishikawa F, Takaku F.
Mol Cell Biol 11 : 2125-2132. 1991
23TYMP
Platelet-derived endothelial cell growth factor.
Miyazono K, Usuki K, Heldin CH.
Prog Growth Factor Res 3 : 207-217. 1991